A recommendation for reduced lidocaine dosage during intravenous regional bretylium treatment of reflex sympathetic dystrophy.
Hanowell
L H
LH
Kanefield
J K
JK
Soriano
S G
SG
D000328:Adult; D001949:Bretylium Compounds / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage* / Q000627:therapeutic use; D012019:Reflex Sympathetic Dystrophy / Q000188:drug therapy*
D001949:Bretylium Compounds; D008012:Lidocaine; C045166:bretylium